Assessment of Lumiracoxib Bioavailability from Targeted Sites in the Human Intestine Using Remotely Activated Capsules and Gamma Scintigraphy

Author： Wilding Ian R.   Connor Alyson L.   Carpenter Polly   Rordorf Christiane   Branson Janice   Milosavljev Slavica   Scott Graham  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.21, Iss.3, 2004-03, pp. : 443-446

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Novel Method to Radiolabel Gastric Retentive Formulations for Gamma Scintigraphy Assessment

By Burke Matthew   Staton J.   Vickers Ann   Peters Erin   Coffin Mark  

Pharmaceutical Research, Vol. 24, Iss. 4, 2007-04 ,pp. : 695-704

Springer Publishing Company

Access to resources Recommend Favorite

Lumiracoxib news from EULAR

By  

Inpharma, Vol. 1, Iss. 1598, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Lumiracoxib news from EULAR

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 533, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Lumiracoxib

By Katherine A. Lyseng-Williamson   Monique P. Curran  

Drugs, Vol. 64, Iss. 19, 2004-01 ,pp. : 2237-2246

Adis International

Access to resources Recommend Favorite

Bioavailability Assessment from Pharmacologic Data: Method and Clinical Evaluation

By Stagni Grazia   Shepherd Alexander M. M.   Liu Yanjuan   Gillespie William R.  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 25, Iss. 3, 1997-06 ,pp. : 349-362

Springer Publishing Company

Access to resources Recommend Favorite